Aesthetics Biomedical, US Dermatology Partners Enter Long-term Partnership

Aesthetics Biomedical® Inc. is entering a long-term partnership with U.S. Dermatology Partners, the largest physician-led dermatology practice in the US, to bring Vivace procedures and ther medical and aesthetic dermatology care advances to patients in more than 90+ locations throughout Arizona, Colorado, Kansas, Maryland, Missouri, Oklahoma, Texas, and Virginia. Vivace® is a minimally invasive, FDA-cleared, radiofrequency microneedling treatment.

This year, U.S. Dermatology Partners installed Vivace® into four initial practices, resulting in more than 170 consumer treatments being sold within the first four weeks. U.S. Dermatology Partners and ABM marketed the Vivace Experience® concept with the objective of delivering an immediate ROI supporting the purchase of the initial device for the organization, the companies say. Vivace® is a primary

driver expected to positively impact U.S. Dermatology Partners’ market growth exponentially and rapidly, already generating significant revenue in six locations across the US, in less than six months. 

"Striving to innovate, generate solid clinical and laboratory research, and to enrich the physician as well as the patient experience are principles that Aesthetics Biomedical® was founded on,” says Aesthetics Biomedical Chief Executive Officer & Founder, MaryAnn Guerra. “It is these foundational principles that have led to our synergy with U.S. Dermatology Partners.”